Poplar POINT Capital Partners L.P. is 10% at NovaBay Pharmaceuticals, Inc. (NBY). They have made 4 open-market trades across 4 companies since 2014, most recently 2025-04-01.
CIK 0001588289
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $595K since 2014, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBY | BUY | 2025-03-26 | 2025-04-15 | $0.60 | $75K | -2.6% | -3.5% | +14.8% |
| GYRO | SELL | 2021-08-27 | 2021-08-30 | $13.03 | $472K | -1.3% | +1.8% | -9.4% |
| SWSH | SELL · Routine | 2016-05-13 | 2016-05-17 | $0.93 | $97K | N/A | N/A | N/A |
| EMRI | BUY | 2015-06-30 | 2015-07-02 | $1.12 | $183K | N/A | N/A | N/A |
| SCMR | BUY | 2014-07-16 | 2014-11-13 | $0.37 | $338K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.